Tryptophan Catabolism and Cancer Immunotherapy Targeting IDO Mediated Immune Suppression-Reference-Cited by-同舟云学术

Tryptophan Catabolism and Cancer Immunotherapy Targeting IDO Mediated Immune Suppression

Published:2017 Issue: Volume: Page:129-144
ISSN:0065-2598
Container-title:Advances in Experimental Medicine and Biology
language:
Short-container-title:

Author:

Amobi Adaobi,Qian Feng,Lugade Amit A.,Odunsi Kunle

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-319-67577-0_9

Reference83 articles.

1. Lob S, et al. Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees? Nat Rev Cancer. 2009;9(6):445–52.

2. Moffett JR, Namboodiri MA. Tryptophan and the immune response. Immunol Cell Biol. 2003;81(4):247–65.

3. Ball HJ, et al. Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. Gene. 2007;396(1):203–13.

4. Metz R, et al. Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. Cancer Res. 2007;67(15):7082–7.

5. Mehler AH, Knox WE. The conversion of tryptophan to kynurenine in liver. II. The enzymatic hydrolysis of formylkynurenine. J Biol Chem. 1950;187(1):431–8.

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The central role of transfer RNAs in mistranslation;Journal of Biological Chemistry;2024-09

2. Exploring the gut microbiota and its potential as a biomarker in gliomas;Biomedicine & Pharmacotherapy;2024-04

3. Different Kynurenine Pathway Dysregulation in Systemic Sclerosis in Men and Women;International Journal of Molecular Sciences;2024-03-29

4. Applications of nanomedicine-integrated phototherapeutic agents in cancer theranostics: A comprehensive review of the current state of research;Nanotechnology Reviews;2024-01-01

5. Tryptophan Metabolism in Human Diseases;Tryptophan in Animal Nutrition and Human Health;2024